Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)–Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group is in the process of selecting core instruments for PsA clinical trials. During a 2-h workshop and breakout group discussion...
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Journal of Rheumatology
2018
|
| _version_ | 1797069480035090432 |
|---|---|
| author | Holland, R Tillett, W Ogdie, A Leung, Y Gladman, D Callis Duffin, K Coates, L Mease, P Eder, L Strand, V Elmamoun, M Højgaard, P Chau, J de Wit, M Goel, N Lindsay, C FitzGerald, O Shea, B Beaton, D Orbai, A |
| author_facet | Holland, R Tillett, W Ogdie, A Leung, Y Gladman, D Callis Duffin, K Coates, L Mease, P Eder, L Strand, V Elmamoun, M Højgaard, P Chau, J de Wit, M Goel, N Lindsay, C FitzGerald, O Shea, B Beaton, D Orbai, A |
| author_sort | Holland, R |
| collection | OXFORD |
| description | The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)–Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group is in the process of selecting core instruments for PsA clinical trials. During a 2-h workshop and breakout group discussions at the GRAPPA 2017 annual meeting in Amsterdam, the Netherlands, participants discussed the first set of candidate instruments to be taken through the OMERACT Filter 2.1 instrument selection process: 66/68 swollen/tender joint count (66/68JC), Spondyloarthritis Consortium of Canada (SPARCC) enthesitis index, patient’s global assessment (GRAPPA and OMERACT formulations), Health Assessment Questionnaire–Disability Index (HAQ-DI), Psoriatic Arthritis Impact of Disease (PsAID) questionnaires 9 and 12, and Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue. Based on the assessment of domain match (content and face validity) and feasibility according to the OMERACT instrument selection criteria, the working group recommends continuing with appraisal of construct validity and discrimination for 66/68JC, SPARCC, PsAID 9 and 12, HAQ-DI, and FACIT-Fatigue. In addition, it recommends repeating the OMERACT Filter 2.1 process for patient global instruments because of insufficient votes. Additional sets of candidate instruments for the PsA core instrument set will be evaluated in a similar process. |
| first_indexed | 2024-03-06T22:25:05Z |
| format | Journal article |
| id | oxford-uuid:5666efa1-34e5-4ecc-9872-e986ead2ee38 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:25:05Z |
| publishDate | 2018 |
| publisher | Journal of Rheumatology |
| record_format | dspace |
| spelling | oxford-uuid:5666efa1-34e5-4ecc-9872-e986ead2ee382022-03-26T16:50:05ZContent and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual MeetingJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5666efa1-34e5-4ecc-9872-e986ead2ee38EnglishSymplectic Elements at OxfordJournal of Rheumatology2018Holland, RTillett, WOgdie, ALeung, YGladman, DCallis Duffin, KCoates, LMease, PEder, LStrand, VElmamoun, MHøjgaard, PChau, Jde Wit, MGoel, NLindsay, CFitzGerald, OShea, BBeaton, DOrbai, AThe Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)–Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group is in the process of selecting core instruments for PsA clinical trials. During a 2-h workshop and breakout group discussions at the GRAPPA 2017 annual meeting in Amsterdam, the Netherlands, participants discussed the first set of candidate instruments to be taken through the OMERACT Filter 2.1 instrument selection process: 66/68 swollen/tender joint count (66/68JC), Spondyloarthritis Consortium of Canada (SPARCC) enthesitis index, patient’s global assessment (GRAPPA and OMERACT formulations), Health Assessment Questionnaire–Disability Index (HAQ-DI), Psoriatic Arthritis Impact of Disease (PsAID) questionnaires 9 and 12, and Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue. Based on the assessment of domain match (content and face validity) and feasibility according to the OMERACT instrument selection criteria, the working group recommends continuing with appraisal of construct validity and discrimination for 66/68JC, SPARCC, PsAID 9 and 12, HAQ-DI, and FACIT-Fatigue. In addition, it recommends repeating the OMERACT Filter 2.1 process for patient global instruments because of insufficient votes. Additional sets of candidate instruments for the PsA core instrument set will be evaluated in a similar process. |
| spellingShingle | Holland, R Tillett, W Ogdie, A Leung, Y Gladman, D Callis Duffin, K Coates, L Mease, P Eder, L Strand, V Elmamoun, M Højgaard, P Chau, J de Wit, M Goel, N Lindsay, C FitzGerald, O Shea, B Beaton, D Orbai, A Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting |
| title | Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting |
| title_full | Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting |
| title_fullStr | Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting |
| title_full_unstemmed | Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting |
| title_short | Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting |
| title_sort | content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials the psa omeract core set workshop at the grappa 2017 annual meeting |
| work_keys_str_mv | AT hollandr contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT tillettw contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT ogdiea contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT leungy contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT gladmand contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT callisduffink contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT coatesl contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT measep contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT ederl contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT strandv contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT elmamounm contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT højgaardp contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT chauj contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT dewitm contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT goeln contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT lindsayc contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT fitzgeraldo contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT sheab contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT beatond contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting AT orbaia contentandfacevalidityandfeasibilityof5candidateinstrumentsforpsoriaticarthritisrandomizedcontrolledtrialsthepsaomeractcoresetworkshopatthegrappa2017annualmeeting |